NLM Logo

EVA regimen MeSH Supplementary Concept Data 2024


MeSH Supplementary
EVA regimen
Unique ID
C087783
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C087783
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Doxorubicin
Etoposide
Vinblastine
Frequency
5
Note
a chemotherapy protocol consisting of the above compounds; used in the treatment of advanced stage Hodgkin's disease; do not confuse with EVA protocol
Source
Cancer 1994 Jul 1;74(1):159-63
Date of Entry
1994/07/15
Revision Date
2000/11/30
EVA regimen Preferred
page delivered in 0.004s